Mangumpit, Erlene .
HRN: 17-32-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2024
CEFUROXIME 750MG (VIAL)
06/18/2024
06/25/2024
IV
390mg
Q8
PCAP C, TC Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes